凯赛生物(688065.SH)拟推2025年员工持股计划

Core Viewpoint - Kaisa Bio (688065.SH) has disclosed a draft employee stock ownership plan for 2025, aimed at enhancing talent retention and attracting skilled personnel [1] Group 1: Employee Stock Ownership Plan Details - The plan includes participation from company directors (excluding independent directors), senior management, middle management, and key technical (business) personnel [1] - The total number of participants in the initial setup of the plan will not exceed 155 individuals, with 6 being directors and senior management [1] - The stock source for the plan will be shares repurchased by the company, specifically from its dedicated repurchase account [1] Group 2: Stock and Financial Details - The number of shares to be held under the employee stock ownership plan will not exceed 1.3 million shares, representing approximately 0.18% of the company's total share capital at the time of the plan's announcement [1] - To support sustainable development and retain talent, the plan reserves 150,000 shares as a reserve, accounting for 11.54% of the total shares in the plan [1] - The purchase price for the shares from the repurchase account is set at 25.53 yuan per share, including the reserved shares [1]